Endoluminal bariatric techniques

Gastrointestinal Endoscopy

Volumn 76, Issue 1, 2012, Pages 1-7

  Kethu, Sripathi R ^a   Banerjee, Subbhas ^a   Barth, Bradley A ^a   Desilets, David J ^a   Kaul, Vivek ^a   Pedrosa, Marcos C ^a   Pfau, Patrick R ^a   Pleskow, Douglas K ^a   Tokar, Jeffery L ^a   Wang, Amy ^a   Wong Kee Song, Louis Michel ^a   Rodriguez, Sarah A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

BALLOON; BARIATRIC SURGERY; BODY MASS; CONTROLLED CLINICAL TRIAL (TOPIC); DIGESTIVE TRACT ENDOSCOPY; DUODENOJEJUNAL BYPASS SLEEVE; ENDOSCOPE; EVIDENCE BASED PRACTICE; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; GUIDE WIRE; HUMAN; MEDLINE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; UNITED STATES; WEIGHT REDUCTION;

EID: 84862698088     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2012.02.020     Document Type: Article

References (49)

1. The World Health Organization 2005 data. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed January 6, 2011.
2. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.
3. Paiva D, Bernardes L, Suretti L. Laparoscopic biliopancreatic diversion: technique and initial results. Obes Surg 2002;12:358-61.
4. Kim WW, Gagner M, Kini S, et al. Laparoscopic vs. open biliopancreatic diversion with duodenal switch: a comparative study. J Gastrointest Surg 2003;7:552-7.
5. Gracia J, Martínez M, Elia M, et al. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg 2009;19:432-8.
6. SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis 2009;5:387-405.
7. Hogan R, Johnston J, Long B, et al. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity. Gastrointest Endosc 1989;35:381-5.
8. Benjamin S, Maher K, Cattau E Jr, et al. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity. Gastroenterology 1988;95:581-8.
9. Mathus-Vliegen E, Tytgat G, Veldhuyzen-Offermans E. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, shamcontrolled, crossover evaluation of 500-milliliter balloon. Gastroenterology 1990;99:362-9.
10. Genco A, Bruni T, Doldi S, et al. BioEnterics Intragastric Balloon: the Italian experience with 2,515 patients. Obes Surg 2005;15:1161-4.
11. Lopez-Nava G, Rubio M, Prados S, et al. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011;21:5-9.
12. Sallet J, Marchesini J, Paiva D, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004;14:991-8.
13. Ganesh R, Rao AD, Baladas HG, et al. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singapore Med J 2007;48:227-31.
14. Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg 2008;18:989-92.
15. Genco A, Cipriano M, Materia A, et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc 2009;23: 1849-53.
16. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or = 50). Obes Surg 2005;15:612-7.
17. Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg 2009;19:1084-8.
18. Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg 2010;20:1128-32.
19. Ricci G, Bersani G, Rossi A, et al. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 2008;18:1438-42.
20. Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010;71:927-33.
21. Busetto L, Enzi G, Inelmen EM, et al. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest 2005;128:618-23.
22. Chan AO, Chow WS, Lam KF, et al. The effect of intragastric balloon placement on weight loss and type 2 diabetes control. Aliment Pharmacol Ther 2008;28:162-4.
23. Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg 2004;14:671-6.
24. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61:19-27.
25. Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes 2006;30:129-33.
26. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008;18:1611-7.
27. Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009;41:575-80.
28. Dumonceau JM, François E, Hittelet A, et al. Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study. Obes Surg 2010;20:692-7.
29. Forestieri P, De Palma GD, Formato A, et al. Heliosphere Bag in the treatment of severe obesity: preliminary experience. Obes Surg 2006;16:635-7.
30. Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg 2010;20:1227-30.
31. Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg 2007;17:764-9. Erratum in: Obes Surg 2007;17:996.
32. Lecumberri E, Krekshi W, Matía P, et al. Effectiveness and safety of airfilled balloon heliosphere BAG® in 82 consecutive obese patients. Obes Surg 2011;21:1508-12.
33. De Castro ML, Morales MJ, Del Campo V, et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg 2010;20:1642-6.
34. Nijhof HW, Steenvoorde P, Tollenaar RA. Perforation of the esophagus caused by the insertion of an intragastric balloon for the treatment of obesity. Obes Surg 2006;16:667-70.
35. Zdichavsky M, Beckert S, Kueper M, et al. Mechanical ileus induces surgical intervention due to gastric balloon: a case report and review of the literature. Obes Surg 2010;20:1743-6.
36. Oztürk A, Akinci OF, Kurt M. Small intestinal obstruction due to self-deflated free intragastric balloon. Surg Obes Relat Dis 2010;6:569-71.
37. Vanden Eynden F, Urbain P. Small intestine gastric balloon impaction treated by laparoscopic surgery. Obes Surg 2001;11:646-8.
38. Cubattoli L, Barneschi C, Mastrocinque E, et al. Cardiac arrest after intragastric balloon insertion in a super-obese patient. Obes Surg 2009;19:253-6. Epub 2008 Jul 10.
39. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010;251:236-43.
40. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010;71:976-82.
41. Escalona A, Yáñez R, Pimentel F, et al. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis 2010;6:126-31.
42. Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008;68:51-8.
43. Devière J, Ojeda Valdes G, Cuevas Herrera L, et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc 2008;22:589-98. Epub 2007 Nov 1. Erratum in: Surg Endosc 2008;22:599.
44. Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008;40:406-13. Erratum in: Endoscopy 2008;40:537.
45. Closset J, Germanova D, Loi P, et al. Laparoscopic gastric bypass as a revision procedure after transoral gastroplasty. Obes Surg 2011;21:1-4.
46. de Jong K, Mathus-Vliegen EM, Veldhuyzen EA, et al. Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointest Endosc 2010;72:497-504.
47. Coskun H, Duran Y, Dilege E, et al. Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model. Obes Surg 2005;15:1137-43.
48. García-Compean D, Mendoza-Fuerte E, Martínez JA, et al. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol 2005;29:789-91.
49. Kencana AP, Rasouli M, Huynh VA, et al. An ingestible wireless capsule for treatment of obesity. Conf Proc IEEE Eng Med Biol Soc 2010;1:963-6.